|Bid||126.18 x 1100|
|Ask||126.14 x 800|
|Day's Range||125.68 - 126.93|
|52 Week Range||79.84 - 129.12|
|Beta (5Y Monthly)||0.58|
|PE Ratio (TTM)||40.10|
|Earnings Date||Feb 18, 2021 - Feb 22, 2021|
|Forward Dividend & Yield||1.44 (1.13%)|
|Ex-Dividend Date||Oct 27, 2020|
|1y Target Est||129.86|
Pandemic-induced demand for pharmaceutical products is likely to drive AptarGroup's (ATR) Pharma segment, while demand in personal care market and home care market will aid the Beauty + Home segment.
Investors can retain AptarGroup (ATR) stock in their portfolio for the time being on upbeat prospects.
AptarGroup's (ATR) top and bottom lines improve on solid growth in the Pharma segment as well as in the food, personal care and home care markets during the July-September period.